ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2022
Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with
Open access · bronzeAbstract read
In one paragraph
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.
0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 53 citations in OpenAlex.
- Full-length 16S rRNA nanopore sequencing enables species resolution ofGut microbes · 2026Article
- The Phylum Fusobacteriota Is Associated with Colorectal Cancer-Specific Mortality: Results from the Translational Research Program in Cancer Differences across Populations.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026Article
- Pathogenic Roles ofPathogens (Basel, Switzerland) · 2026Review
- Fusobacterium nucleatum manipulates host autophagy to promote its intracellular survival and treatment resistance in nasopharyngeal carcinoma.Molecular cancer · 2026Article
- Article
- The Role of Gut Microbiota and Mucin Barrier in the Pathogenesis of Colorectal Cancer.Current issues in molecular biology · 2025Review
- Control of Dental Plaque and Gingival Inflammation by Natural Ingredients-Based Mouthwash.Dentistry journal · 2025Article
- Metaplasia Enables Stomach Colonization bybioRxiv : the preprint server for biology · 2025Article
- Addressing controversy inGut microbes · 2025Article
- Primary tumor microbiomes predict distant metastasis of colorectal cancer.NPJ precision oncology · 2025Article
- Positive selection at core genes may underlie niche adaptation in Fusobacterium animalis.Gut pathogens · 2025Article
- Appendectomy and Long-term Colorectal Cancer Incidence, Overall and by Tumor Fusobacterium nucleatum Status.Annals of surgery · 2025Article
- Significance ofPolish journal of microbiology · 2025Article
- Fusobacterium nucleatum is enriched in invasive biofilms in colorectal cancer.NPJ biofilms and microbiomes · 2025Article
- Mucosal Microbiome Markers of Complete Pathologic Response to Neoadjuvant Therapy in Rectal Carcinoma.Cancer research communications · 2025Article
- Establishment and improvement of genetic manipulation tools forEngineering microbiology · 2025Review
- Development of a conditional plasmid for gene deletion in non-modelApplied and environmental microbiology · 2025Article
- Review
- Article
- Article
Corrections and comments
- Commented on by
Authors and funding
40 authors at 19 institutions in 6 countries.
Ivan Borozan *Ontario Institute for Cancer Research, Toronto, Ontario, Canada.ORCID 0000-0002-3145-3550
Syed H Zaidi *Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Tabitha A HarrisonPublic Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.ORCID 0000-0002-4173-7530
Amanda I PhippsPublic Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.
Jiayin ZhengPublic Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.ORCID 0000-0002-5559-6847
Stephen LeeOntario Institute for Cancer Research, Toronto, Ontario, Canada.ORCID 0000-0002-9402-4331
Quang M TrinhOntario Institute for Cancer Research, Toronto, Ontario, Canada.ORCID 0000-0002-3602-2290
Robert S SteinfelderPublic Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.
Jeremy AdamsOntario Institute for Cancer Research, Toronto, Ontario, Canada.
Barbara L BanburyPublic Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.ORCID 0000-0001-7332-7117
Sonja I BerndtDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Stefanie BrezinaInstitute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-5238-6900
Daniel D BuchananColorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia.ORCID 0000-0003-2225-6675
Susan BullmanHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Yin CaoDivision of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St. Louis, St Louis, Missouri.
Alton B FarrisPathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.ORCID 0000-0001-5534-7763
Jane C FigueiredoDepartment of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.ORCID 0000-0001-8040-3341
Marios GiannakisDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Lawrence E HeislerOntario Institute for Cancer Research, Toronto, Ontario, Canada.
John L HopperThe University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.
Yi LinPublic Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.
Xuemei LuoOntario Institute for Cancer Research, Toronto, Ontario, Canada.
Reiko NishiharaDepartment of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Elaine R MardisThe Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio.ORCID 0000-0002-5892-1553
Nickolas PapadopoulosLudwig Center for Cancer Genetics and Therapeutics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Baltimore, Maryland.
Conghui QuPublic Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.
Emma E G ReidOntario Institute for Cancer Research, Toronto, Ontario, Canada.
Stephen N ThibodeauDivision of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Sophia HarlidOncology, Department of Radiation Sciences, Faculty of Medicine, Umeå University, Umeå, Sweden.ORCID 0000-0001-8540-6891
Caroline Y UmBehavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia.ORCID 0000-0001-5449-6230
Li HsuPublic Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.ORCID 0000-0001-8168-4712
Andrea GsurInstitute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-9795-1528
Peter T CampbellBehavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia.ORCID 0000-0002-5549-2036
Steven GallingerOntario Institute for Cancer Research, Toronto, Ontario, Canada.
Polly A NewcombPublic Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.
Shuji OginoDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-3909-2323
Wei SunPublic Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington.ORCID 0000-0002-6350-1107
Thomas J HudsonOntario Institute for Cancer Research, Toronto, Ontario, Canada.ORCID 0000-0002-1376-4849
Vincent FerrettiOntario Institute for Cancer Research, Toronto, Ontario, Canada. upeters@fredhutch.org vincent.ferretti.hsj@ssss.gouv.qc.ca.
Ulrike PetersPublic Health Sciences Division, Fred Hutchinson Cancer Research Centre, Seattle, Washington. upeters@fredhutch.org vincent.ferretti.hsj@ssss.gouv.qc.ca.ORCID 0000-0001-5666-9318
Ontario Institute for Cancer Research · CAFred Hutch Cancer Center · USUniversity of Washington · USAmerican Cancer Society · USComprehensive Cancer Center Vienna · ATBrigham and Women's Hospital · USBroad Institute · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZACedars-Sinai Medical Center · USEmory University · USHarvard University · USMayo Clinic · USNational Cancer Institute · USNationwide Children's Hospital · USSidney Kimmel Comprehensive Cancer Center · USThe Royal Melbourne Hospital · AUUmeå University · SEVictorian Comprehensive Cancer Centre · AUWashington University in St. Louis · US
Funding
Molecular pathological epidemiology of colorectal cancerU01CA137088 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 2009 to 2018
$21.8MData sharing: the Colon Cancer Family Registry CohortU01CA167551 · NCI · UNIVERSITY OF MELBOURNE · PI Daniel David BUCHANAN, Steven Gallinger · 2018 to 2026
$16.8MSEATTLE FAMILIAL COLORECTAL CANCER REGISTRYU01CA074794 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWCOMB, POLLY A · 1997 to 2007
$14.1MONTARIO REGISTRY FOR STUDIES OF FAMILIAL COLON CANCERU01CA074783 · NCI · CANCER CARE ONTARIO · PI GALLINGER, STEVEN · 1997 to 2008
$12.5MDetection of Colorectal Cancer Susceptibility Loci Using Genome-Wide SequencingU01CA164930 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 2012 to 2015
$12.4MThe Colon Cancer Family Registry: SeattleU24CA074794 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWCOMB, POLLY A · 2008 to 2011
$7.0MPrecision Prevention Research ProgramR35CA253185 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Andrew T Chan · 2020 to 2026
$6.9MSpatial Immunopathological Epidemiology of Colorectal Adenoma-Carcinoma SpectrumR01CA248857 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Jonathan Andrew Nowak, Shuji Ogino · 2020 to 2026
$6.6MAccelerating Transdisciplinary Epidemiology of Colorectal CancerR35CA197735 · NCI · DANA-FARBER CANCER INST · PI OGINO, SHUJI · 2015 to 2021
$6.0MThe Colon Cancer Family Registry: OntarioU24CA074783 · NCI · CANCER CARE ONTARIO · PI GALLINGER, STEVEN · 2008 to 2011
$4.1MMolecular Correlates of Outcomes in Clinical Trials of Colon CancerR01CA176272 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CHAN, ANDREW T, NEWCOMB, POLLY A · 2013 to 2017
$2.5MHormones and Colon Cancer: Epigenetic Subtypes, Risk, and SurvivalR01CA076366 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWCOMB, POLLY A · 1998 to 2009
$2.4MCancer Research UK 27140NCI NIH HHS R01 CA076366NCI NIH HHS R01 CA176272NCI NIH HHS R01 CA248857NCI NIH HHS R35 CA197735NCI NIH HHS R35 CA253185NCI NIH HHS U01 CA074783NCI NIH HHS U01 CA074794NCI NIH HHS U01 CA137088NCI NIH HHS U01 CA164930NCI NIH HHS U01 CA167551NCI NIH HHS U24 CA074783NCI NIH HHS U24 CA074794
Abstract
background
methodsWe characterized
results
conclusionsIMPACT: Our findings identify the
Indexed as
Colorectal NeoplasmsFusobacterium nucleatumCarcinogenesisHumansRNA, Ribosomal, 16SRNA, Ribosomal, 16S
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.